CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.

about

Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life.

P2860

Q47244918-98763DCC-BEFA-4203-9D2B-F77424336451

P2860

CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.

Item

http://www.wikidata.org/entity/Q47972233

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CGRP and PTX3 as Predictors of ...... raine: An Observational Study.

@en

CGRP and PTX3 as Predictors of ...... raine: An Observational Study.

@nl

type

Item

label

CGRP and PTX3 as Predictors of ...... raine: An Observational Study.

@en

CGRP and PTX3 as Predictors of ...... raine: An Observational Study.

@nl

prefLabel

CGRP and PTX3 as Predictors of ...... raine: An Observational Study.

@en

CGRP and PTX3 as Predictors of ...... raine: An Observational Study.

@nl

P1476

CGRP and PTX3 as Predictors of ...... graine: An Observational Study

@en

P2093

Alba Vieites-Prado

http://www.w3.org/2001/XMLSchema#string

Ana López

http://www.w3.org/2001/XMLSchema#string

Francisco Campos

http://www.w3.org/2001/XMLSchema#string

Francisco Martínez

http://www.w3.org/2001/XMLSchema#string

José Castillo

http://www.w3.org/2001/XMLSchema#string

María Pérez-Mato

http://www.w3.org/2001/XMLSchema#string

Xiana Rodríguez-Osorio

http://www.w3.org/2001/XMLSchema#string

P2860

The International Classification of Headache Disorders, 3rd edition (beta version)

Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability.

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains.

Diencephalic and brainstem mechanisms in migraine.

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.

Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks.

Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine

Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.

Activation of central trigeminovascular neurons by cortical spreading depression

P304

78-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HEAD.13211

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tomás Sobrino

Rogelio Leira

Clara Domínguez

P577

2017-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29131327

http://www.w3.org/2001/XMLSchema#string

CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.

about

P2860

P2860

CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698